Fantastic News for Broadcom Stock Investors

Broadcom reported fiscal Q3 2026 revenue of $29.6 billion, up 86% year over year, adjusted EPS of $3.32, up 96%, and free cash flow of $13.7 billion, up 95%. AI-chip revenue rose 221% to $16.7 billion, but shares declined after its $34.8 billion Q4 revenue outlook came in slightly below Wall Street expectations. Management forecasts roughly $115 billion in AI semiconductor revenue for fiscal 2027, supported by demand exceeding supply and long-term custom-chip partnerships with hyperscalers including Meta and Alphabet.

Analysis

The market is likely discounting AVGO's guidance miss as evidence that AI infrastructure demand is normalizing, but the more important variable is mix: custom accelerators and networking attach revenue can sustain earnings growth even as headline growth decelerates. AVGO's economics improve if hyperscalers shift repeatable inference workloads from merchant GPUs to ASICs, because customers commit to multiyear design cycles and switching costs rise after software/hardware co-optimization. The key diligence item is whether the implied fiscal-2027 AI revenue target reflects contracted programs versus management's addressable-demand estimate; the latter would justify a materially lower multiple.

The second-order effect is not simply negative for NVDA. ASIC deployment is most disruptive to GPU demand in mature, high-volume inference workloads, while NVDA retains the higher-value training, frontier-model, and general-purpose compute layers. This favors a barbell of AVGO and NVDA over a broad semiconductor-beta exposure: both can win under continued AI capex, but AVGO offers relative upside if hyperscalers prioritize cost-per-token and internal silicon. TSMC (TSM) and advanced-packaging equipment beneficiaries should also capture the volume regardless of which compute architecture wins.

Near term, AVGO needs a cleaner estimate-reset cycle before the stock can rerate; a single below-consensus revenue guide is less important than any reduction in AI program visibility, gross-margin pressure from new ramps, or evidence that customers are delaying deployment. Over 1-3 months, hyperscaler capex commentary and AVGO's next order/backlog disclosure are the catalysts. Over 6-18 months, the structural upside depends on custom-chip adoption translating into production volumes rather than design wins; falsify the thesis if fiscal-2027 AI guidance falls below roughly $100 billion, or if AI-related gross margin compresses materially despite revenue growth.

Key Decisions for Investors

• Accumulate AVGO in tranches over the next 2-6 weeks rather than chase an initial rebound; target a 12-month 20-30% return if AI revenue visibility is reaffirmed, with a risk stop/review on a material cut to fiscal-2027 AI expectations or a break below the post-earnings low.
• Initiate a 6-12 month long AVGO / short SOXX pair, sized beta-neutral. This isolates custom-silicon and networking share gains from a broad semiconductor de-rating; exit if hyperscaler capex guidance turns negative or AVGO's AI margin trajectory deteriorates.
• Maintain NVDA exposure rather than treating AVGO's ASIC growth as a direct zero-sum displacement. Prefer a smaller long AVGO / long NVDA barbell versus short NVDA, since aggregate AI infrastructure spending can support both; reassess the relative weighting after META and GOOG disclose 2027 capex and internal-silicon deployment data.
• Add TSM as a lower-idiosyncratic supply-chain expression only after confirming advanced-packaging capacity and pricing remain tight. The trade fails if customer design activity does not convert to wafer starts or if packaging utilization weakens despite announced AI programs.